Chipmaker Rout & Oil Plunge Shake Markets; AI Health Deals

No qualifying small-to-medium practice acquisition or group-practice sale appeared in this week’s healthcare candidates. The strongest deal-adjacent activity centered on venture funding rounds for healthcare technology and services companies — the most notable of which are detailed below.

Flourish Health closes $26M round for youth mental health. Flourish Health, a startup delivering intensive in-home mental healthcare to children and young adults with serious, complex behavioral health needs, secured $26 million in new funding. The round is intended to scale the company’s care model, which is designed to serve patients who typically fall between inpatient and traditional outpatient settings. No lead investor or valuation was disclosed.

Candid Health raises $120M for AI revenue cycle platform. Candid Health closed a $120 million Series D round to expand its artificial-intelligence-powered revenue cycle management (RCM) platform. The round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC, and Y Combinator. The company targets the prior-authorization and claims-processing burdens that remain a persistent administrative drag across independent and group practices.

Crystalys Therapeutics adds $130M for gout drug trials. Crystalys Therapeutics secured an additional $130 million to fund pivotal clinical testing of dotinurad, its candidate drug for gout — an inflammatory condition the company describes as having few treatment options. The drug shares a mechanism of action with a molecule that Sobi previously added to its pipeline through a $950 million acquisition, lending competitive context to the raise.

A volatile week in global markets is defined by a sharp drop in oil prices, a continuing selloff in semiconductor stocks, and fresh geopolitical uncertainty tied to the US–Iran conflict and its spillover effects on energy, luxury goods, and investor sentiment.

Chipmakers drag US stocks lower for a third consecutive session. US equities erased an early rally on Monday as chipmakers extended their losing streak, sending the Philadelphia Semiconductor Index toward its third straight session of declines. The selling pressure reflects growing scrutiny of whether the largest spenders on artificial intelligence infrastructure can justify the scale of their investments — a theme gaining momentum across financial commentary. S&P Global Ratings recently downgraded Oracle’s long-term issuer credit rating to BBB-, just one notch above junk status, citing the company’s massive data center and on-site power spending.

Oil sinks as the US pauses strikes on Iran. Crude oil prices fell sharply after the United States paused nearly two weeks of daily military strikes against Iran, easing the immediate supply-disruption premium built into markets. Corn and soybean futures also dropped on the news, recording their steepest single-session declines in months. However, traders remain on edge: satellite imagery showed smoke appearing at multiple Saudi oil facilities over the prior 48 hours, attributed to attacks by Iran-backed militias, leaving the medium-term supply outlook uncertain. President Trump stated he remains prepared to order a return to expanded military operations if diplomatic talks fail.

LVMH fashion unit squeezed by Middle East conflict. LVMH reported that its flagship fashion and leather goods division — home to Louis Vuitton and Dior — barely returned to growth last quarter, its first positive reading in nearly two years. The Financial Times attributed the muted recovery partly to the Iran conflict deterring wealthy shoppers, even as the Dior brand showed individual signs of a rebound. The result underscores how geopolitical instability is now rippling directly into consumer spending at the luxury tier.

New Fed chief and the rate-hike question. Market participants are closely watching the new Federal Reserve chair’s communications approach after the European Central Bank held rates steady last week. ECB president Christine Lagarde cautioned against over-interpreting rapid swings in energy prices while the Middle East conflict remains unresolved. The question facing the Fed is whether any surprise rate move — up or down — would be interpreted as a deliberate market signal or as reactive confusion, with analysts noting that recent decades’ surprise moves were reserved for genuine emergencies, not routine recalibration.

Jersey Mike’s IPO draws outsized demand. The Jersey Mike’s Subs initial public offering attracted investor demand for more than ten times the available shares ahead of its expected pricing on Wednesday, according to people familiar with the matter. The oversubscription signals that appetite for consumer brand IPOs remains strong even amid broader equity market turbulence driven by tech and energy volatility.